FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

31 results

fycompa
(perampanel)
Eisai Inc.
Usage: FYCOMPA is indicated for the treatment of partial-onset seizures in patients aged 4 and older, and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 12 and older with epilepsy.
keppra
(levetiracetam)
UCB, Inc.
Usage: KEPPRA is indicated for treating partial-onset seizures in patients aged 1 month and older. It is also approved as adjunctive therapy for myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy and for primary generalized tonic-clonic seizures in patients 6 years and older with idiopathic generalized epilepsy.
lacosamide
(Lacosamide)
Zydus Pharmaceuticals USA Inc.
Usage: Lacosamide is indicated for the treatment of partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.
lacosamide
(lacosamide)
Sintetica US LLC
Usage: Lacosamide Injection is indicated for the treatment of partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.
lacosamide
(Lacosamide)
Zydus Pharmaceuticals USA Inc.
Usage: Lacosamide is indicated for treating partial-onset seizures in patients aged 4 and older and as adjunctive therapy for primary generalized tonic-clonic seizures in the same age group.
lamotrigine
(lamotrigine extended-release)
Yiling Pharmaceutical, Inc.
Usage: Lamotrigine Extended-Release Tablets are indicated for adjunctive therapy in patients aged 13 and older with primary generalized tonic-clonic seizures and partial-onset seizures. They can also be used for conversion to monotherapy in individuals with partial-onset seizures on a single antiepileptic drug. Safety is not established in patients under 13.
lamotrigine
(lamotrigine extended-release)
Camber Pharmaceuticals Inc
Usage: Lamotrigine Extended-Release Tablets are indicated as adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures in patients aged 13 and older. It is also indicated for conversion to monotherapy for partial-onset seizures in the same age group. Safety in patients under 13 has not been established.
lamotrigine
(Lamotrigine)
Aurobindo Pharma Limited
Usage: Lamotrigine tablets for oral suspension are indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut seizures in patients aged 2 and older. They are also used for maintaining bipolar I disorder, delaying mood episode occurrences, but not for treating acute episodes.
lamotrigine
(Lamotrigine)
Taro Pharmaceuticals U.S.A., Inc.
Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut syndrome seizures in patients aged 2 and older, and for conversion to monotherapy in adults with partial-onset seizures. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes.
lamotrigine
(Lamotrigine)
Northstar Rx LLC.
Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut syndrome seizures in patients aged 2 and older. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes, but not for acute episodes.

Medications for Bilateral Tonicclonic Seizure With Generalized Onset

fycompa

keppra

lacosamide

lacosamide

lacosamide

lamotrigine

lamotrigine

lamotrigine

lamotrigine

lamotrigine